U.S. Stock News

Stanley Black & Decker (SWK) just turned the corner on profitability after years of declining earnings, reporting a projected earnings growth rate of 30.2% per year that outpaces both its industry and the broader US market. Revenue, however, is forecast to grow at a slower clip of 3.9% per year, trailing the US market’s expected 10.5% gain. The company’s return to profitability comes after a notable one-off loss of $525.6 million over the last twelve months, putting renewed focus on the...

Nuvation Bio (NUVB) posted another year of widening losses, with its net income declining at an average annual rate of 45.2% over the past five years. Still, analysts expect revenue to surge by 51.23% per year, outpacing the broader US market’s average growth of 10.5%. Despite the robust outlook, shares currently trade at $4.83, well below the company’s estimated fair value of $19.43 based on a discounted cash flow model. Profitability remains elusive and margins show no signs of meaningful...

Marriott International (MAR) posted a net profit margin of 35.1% for the latest period, down from last year’s 42.1% margin. Earnings growth turned negative after averaging a robust 32.4% per year over the past five years. Looking ahead, the company is forecast to grow earnings at 10.13% annually, which trails the broader US market’s 16%. However, revenue growth projections of 26.2% per year outpace market expectations. Despite strong historical growth, declining margins and a relatively high...

CorVel (CRVL) delivered high quality results in its latest earnings release, reporting a net profit margin of 11.3% compared to 9.6% last year. Over the past year, earnings growth accelerated to 29.2% against a five-year average of 15.3%. This reflects notable momentum and improved profitability that stands out in the company’s recent performance. Investors may see the combination of margin expansion and rapid earnings growth as a strong positive, even as valuation ratios suggest the shares...

Gaia (GAIA) remains in the red, recording unprofitable results with net losses worsening at an average annual rate of 48.7% over the past five years. Despite the ongoing losses, forecasts now point to rapid improvement, with earnings expected to grow by 95.93% per year and a return to profitability within three years. This would outpace most of the market. Meanwhile, revenue growth is set to reach 14.1% annually, which exceeds the predicted 10.5% average across the US market. At a trading...

Transcat (TRNS) reported earnings per share that have grown at an annual rate of 11.8% over the past five years, with profits expected to accelerate further by 22.7% per year over the next three years. Revenue growth is forecast at 7.8% per year, slower than the broader US market's 10.5% pace. The current net profit margin sits at 3.8%, down from 6.6% last year. Shares trade at $62.35, which is well above an estimated fair value of $28.49. The price-to-earnings ratio stands at 51.2x, far...

Verastem (VSTM) is on track for standout top-line growth, with revenue forecast to surge 55.7% per year, well ahead of the broader US market’s 10.5% pace. Despite this bullish revenue outlook, the company remains unprofitable and is projected to stay in the red for at least the next three years, as losses have risen by 23.7% per year over the past five years without net margin improvement. Investor focus this quarter will be on whether Verastem can turn strong growth potential into a path...

Centerspace (CSR) is forecasting a steep annual earnings decline of 36.6% over the next three years, even as revenue is expected to grow modestly at 2.2% per year, trailing the broader US market’s 10.5% pace. While the company has recently turned profitable, reported net profits were boosted by a one-off gain of $52.9 million. Its average annual earnings have fallen by 16% over the past five years. With growth rates lagging and profit quality impacted by non-recurring items, investors may...

IDEAYA Biosciences (IDYA) reported a 45.2% per year increase in losses over the past five years and is forecasted to remain unprofitable for at least the next three years. However, revenue is projected to grow at 28.3% per year, notably outpacing the US market average of 10.5%. With robust top-line growth but continuing net losses, the results reflect a company in high-growth mode with persistent profitability hurdles for investors to watch. See our full analysis for IDEAYA Biosciences. Next,...

Integral Ad Science Holding (IAS) posted current net profit margins of 7.9%, improving from 6.4% a year ago, while earnings grew 42.9% over the last twelve months. This is an impressive figure, though it remains below the robust five-year average growth rate of 73.5% per year. Looking ahead, analysts project revenue to rise at 10.1% per year and forecast significant earnings growth at 23.1% per year, both pointing to momentum outpacing much of the US market. With margins expanding and growth...

AudioCodes (NasdaqGS:AUDC) delivered a 13.4% jump in earnings over the past year, reversing a trend that has seen average annual declines of 18.9% over the past five years. Net profit margin edged up to 5.7% compared to last year's 5%, even as forecasts call for a -6.4% average annual decline in earnings over the next three years. The current setup puts undervaluation in the spotlight as investors weigh whether recent improvements in margins and profitability can last amid muted growth...

Neuronetics (STIM) is currently unprofitable, with annual losses widening by 10.3% on average over the past five years. Despite no improvement in net profit margin and the expectation that the company will remain unprofitable for at least the next three years, revenue is forecast to climb 12.1% a year, outpacing the broader US market’s 10.5% growth rate. Investors are likely to weigh the company’s above-average growth prospects and relatively attractive price-to-sales ratio of 1.5x against...

Life Time Group Holdings (LTH) posted robust earnings momentum, with net profit surging 101.6% year-over-year and profit margins improving to 9.9% from 5.7% the previous year. Investors saw earnings climb 73.2% per year on average over the past five years, while forecasts call for continued double-digit growth. For investors, the company’s steady profit expansion, improving margins, and appealing relative valuation set a strong tone for this earnings cycle. See our full analysis for Life Time...

Insperity (NSP) reported net profit margins of 0.3%, down sharply from 1.8% a year ago, with historical earnings having declined by 9.9% per year over the last five years. Looking ahead, forecasts anticipate a significant rebound, as earnings are projected to grow by 80.7% per year. However, revenue growth is expected at a slower 7% annually, trailing the broader US market’s 10.5%. As a result, investors are weighing recent margin pressure against robust profit growth expectations in the...

Gartner (IT) reported a 19.8% annual earnings growth rate over the last five years, but recent figures reveal net profit margins fell to 13.7% from 17.3% a year ago, with year-on-year earnings now declining. Despite the slowdown in profit growth, earnings are projected to rise 3.2% annually and revenue is forecast to grow 5.2% per year, both trailing broader US market expectations. With three key rewards identified: long-term earnings growth, ongoing profit or revenue expansion, and signs of...

Bancorp 34 (BCTF) recently returned to profitability, reversing its net profit margin compared to the prior period. Despite this progress, earnings have declined by 7.4% per year on average over the past five years. Its price-to-earnings ratio of 15.6x remains higher than both the US Banks industry average of 11x and the peer average of 11.6x. While the company is recognized for high quality earnings, the higher valuation multiples and lingering risks around future growth may weigh on...

NNN REIT (NNN) reported revenue growth forecasts of 4.5% per year, trailing the broader US market’s 10.5% pace, while earnings are projected to grow 3.3% annually, also behind the US average of 16%. The company’s net profit margin stands at 43.1%, down from 45.6% last year, and after delivering 13.7% annual earnings growth over five years, earnings slipped into negative territory in the most recent period. With the current share price coming in significantly below estimated fair value and a...

Cabot (CBT) reported a net profit margin of 8.9%, down from 9.4% last year, and its earnings have contracted over the past year following several years of robust growth averaging 43.1% annually. The company is forecast to grow revenue at 2.3% per year, trailing the broader US market’s expected 10.5% growth rate. Its $61.24 share price trades at a considerable discount to its estimated fair value. With high quality earnings and an attractive dividend, investors may weigh reasonable long-term...

Anywhere Real Estate (HOUS) is currently unprofitable, with losses over the past five years growing at an annual rate of 18.2%. Shares are trading at $10.98, below the estimated fair value of $16.31 based on discounted cash flow analysis. Earnings are forecast to rebound sharply, with 128.7% annual EPS growth expected, and the company is projected to return to profitability within three years. However, revenue is only forecast to rise by 8.4% per year, which trails the broader US market’s...

Solaris Energy Infrastructure (SEI) delivered a jump in net profit margin to 6.7% from last year’s 4.5%, riding a powerful 185.3% annual earnings growth that leaves its five-year average of 51.1% behind. Forecasts point to revenue growing 22.1% per year and an earnings climb of 41.4% per year, both well ahead of the broader US market pace. In this context of robust profitability, investors have to weigh a below-fair-value share price of $53.71 versus a discounted cash flow estimate of...

SNDL (NasdaqCM:SNDL) narrowed its losses by an average of 16.4% per year over the last five years, with forecasts now calling for explosive 168.19% annual earnings growth and a move to profitability within three years. While revenue is anticipated to grow just 2.8% per year, lagging the US market’s 10.5% rate, shares have remained volatile in recent months and stability is still elusive. Investors are weighing this rapid progress on the earnings front and SNDL’s discounted Price-to-Sales...

Great Lakes Dredge & Dock (GLDD) delivered a standout earnings result, posting a 36.3% increase in earnings over the past year, well ahead of its five-year average growth of 4.1% per year. The company’s net profit margin improved to 9.7%, up from 8% previously. This signals stronger profitability and efficiency even as the stock trades at $12.77, a premium relative to one benchmark of fair value. With high-quality earnings and a steady track record of growing profit or revenue, GLDD’s results...

Vitesse Energy (VTS) reported a net profit margin of 8.4%, well below last year’s 19.8%, as the company’s most recent period saw negative earnings growth despite averaging 24.1% annual earnings growth over the past five years. Looking ahead, revenue is projected to grow at just 0.9% per year, lagging the wider US market’s 10.5% average, and earnings are expected to drop sharply by 68.5% per year over the next three years. With shrinking margins and a premium 38.6x price-to-earnings ratio, the...

AC Immune (ACIU) remains unprofitable, with its net profit margin still negative. The company has narrowed its losses by an average of 5.9% annually over the past five years. Looking ahead, earnings are forecast to jump 66.51% per year and consensus expects profitability within three years. Revenue is set to rise 55.6% per year, outpacing the broader US market's projected growth of 10.5%. Despite a higher price-to-book ratio of 4.2x compared to the US Biotech industry's 2.5x, ACIU shares are...